Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026
Same author

Prevalence and Recovery of Arrhythmia-Induced Cardiomyopathy in Patients With Newly Diagnosed Heart Failure Using a Wearable Defibrillator: A Real-World Cohort Study.

Journal of cardiovascular electrophysiology·2026
Same author

[Orbital pathology, not always caused by endocrine factors].

Praxis·2026
Same author

Current management of eosinophilic granulomatosis with polyangiitis across Europe: insights from a multinational expert survey.

Rheumatology (Oxford, England)·2026
Same author

First profiling of the national Swiss Clinical Quality Management giant cell arteritis and polymyalgia rheumatica registry.

Clinical and experimental rheumatology·2026
Same author

Comparative 1-year outcomes of pentaspline versus circular array pulsed field ablation for pulmonary vein isolation with adjunctive atrial lines.

Heart rhythm·2026
Same journal

Nicotinamide adenine dinucleotide phosphate oxidase 4 in lung disease: a review of its biology and therapeutic potential.

Experimental biology and medicine (Maywood, N.J.)·2026
Same journal

Phenotypic profiling of Pathogen Box compounds MMV667494 and MMV028694 in bloodstream-form <i>Trypanosoma brucei brucei</i>.

Experimental biology and medicine (Maywood, N.J.)·2026
Same journal

High systolic blood pressure and stroke: evidence from the NHANES 1999-2023 and global burden of disease 2021.

Experimental biology and medicine (Maywood, N.J.)·2026
Same journal

Scaling human liver microphysiological systems: implementing a higher-throughput liver acinus microphysiological system platform.

Experimental biology and medicine (Maywood, N.J.)·2026
Same journal

Race, oxygen exposure, and retinopathy of prematurity: re-examining a persistent epidemiologic paradox.

Experimental biology and medicine (Maywood, N.J.)·2026
Same journal

Peripheral immune cells and glycation indices as potential diagnostic biomarkers in amyotrophic lateral sclerosis.

Experimental biology and medicine (Maywood, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Apr 26, 2026

Micropatterning and Assembly of 3D Microvessels
13:05

Micropatterning and Assembly of 3D Microvessels

Published on: September 9, 2016

11.4K

Tissue-engineered microenvironment systems for modeling human vasculature.

Anna Tourovskaia1, Mark Fauver1, Gregory Kramer1

  • 1Nortis, Inc., Seattle, WA 98195, USA.

Experimental Biology and Medicine (Maywood, N.J.)
|July 18, 2014
PubMed
Summary
This summary is machine-generated.

Researchers developed a microfluidic chip to create tissue-engineered microenvironment systems (TEMS) that better model human vascularized tissues. This novel in vitro system aids in predicting drug efficacy and disease progression more accurately.

Keywords:
Microfluidic devicebody-on-chipmicroenvironmentmicrophysiological systemmicrovasculatureorgan-on-chiptissue engineering

More Related Videos

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

2.6K
Perfusable Vascular Network with a Tissue Model in a Microfluidic Device
07:05

Perfusable Vascular Network with a Tissue Model in a Microfluidic Device

Published on: April 4, 2018

13.7K

Related Experiment Videos

Last Updated: Apr 26, 2026

Micropatterning and Assembly of 3D Microvessels
13:05

Micropatterning and Assembly of 3D Microvessels

Published on: September 9, 2016

11.4K
Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

2.6K
Perfusable Vascular Network with a Tissue Model in a Microfluidic Device
07:05

Perfusable Vascular Network with a Tissue Model in a Microfluidic Device

Published on: April 4, 2018

13.7K

Area of Science:

  • Biotechnology
  • Biomaterials Engineering
  • Vascular Biology

Background:

  • High attrition rates in drug development necessitate improved in vitro models.
  • Conventional 2D cultures and animal models have limitations in predicting clinical outcomes.
  • 3D cell arrangements, co-cultures, and physico-chemical cues enhance predictive power of in vitro systems.

Purpose of the Study:

  • To develop a microfluidic chip for creating tissue-engineered microenvironment systems (TEMS).
  • To engineer perfusable tubular tissue structures that mimic human microvasculature.
  • To provide a tool for modeling vascularized human tissue microenvironments in vitro.

Main Methods:

  • Designed a microfluidic chip with a chamber for extracellular matrix (ECM) and tubular channels.
  • Seeded endothelial cells (ECs) into channels to form perfusable tubular tissue structures.
  • Connected engineered tissues to fluidic channels for perfusion.

Main Results:

  • Successfully created models of angiogenesis, blood-brain barrier (BBB), and tumor-cell extravasation.
  • Angiogenesis model demonstrated true sprouting in response to growth factor gradients.
  • BBB model incorporated brain-specific ECs, astrocytes, and pericytes.
  • Tumor-cell extravasation model allowed visualization and measurement of tumor cell migration.

Conclusions:

  • The developed microfluidic chip technology enables the creation of TEMS.
  • These TEMS recapitulate structural, functional, and physico-chemical aspects of vascularized human tissues.
  • The technology offers a promising tool for in vitro drug development and disease modeling.